Petarte, Melodina T.
HRN: 22-04-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/03/2022
11/09/2022
IV
1.5g
Q8
CAP LR; Presumptive PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice